Skip to main content
SpringerLink
Log in

Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis

Molecular Neurobiology Aims and scope Submit manuscript

Cite this article

Abstract

Diabetic peripheral neuropathy (DPN) is a microvascular complication of diabetes mellitus. The aim of this meta-analysis was to evaluate the effects of methylenetetrahydrofolate reductase (MTHFR) 677 C>T and ACE I/D polymorphisms in the development of DPN. We systematically reviewed published studies on MTHFR 677 C>T and ACE I/D polymorphisms and DPN found in various types of electronic databases. Strengthening the Reporting of Observational studies in Epidemiology (STROBE) quality score systems were used to determine the quality of the articles selected for inclusion. Odds ratios (ORs) and its corresponding 95 % confidence interval (95 % CI) were calculated. We used STATA statistical software (version 12.0, Stata Corporation, College Station, TX, USA) to deal with statistical data. Our results indicated an association of ACE D>I mutation (OR = 1.43, 95 % CI 1.12–1.83, P = 0.004) and MTHFR 677 C>T mutation (OR = 1.43, 95 % CI 1.08–1.90, P = 0.014) with DPN under the allele model, and similar results were also found under the dominant model (all P < 0.05). Subgroup analysis by country indicated that the MTHFR 677 C>T polymorphism may be the main risk factor for DPN in Turkey under four genetic models. ACE D>I mutation was correlated with DPN in Japanese and Pakistani populations in the majority of groups. The relationships of MTHFR 677 C>T and ACE I/D polymorphisms with DPN patients presented in this meta-analyses support the view that the MTHFR and ACE genes might play an important role in the development of DPN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293

    Article  PubMed  PubMed Central  Google Scholar 

  2. Varkonyi T, Kempler P (2008) Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 10:99–108

    CAS  PubMed  Google Scholar 

  3. Yan JE, Yuan W, Lou X et al (2012) Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of Toll-like receptor 4 expression. Neurosci Lett 526:54–58

    Article  CAS  PubMed  Google Scholar 

  4. Wong MC, Chung JW, Wong TK (2007) Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 335:87

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Monastiriotis C, Papanas N, Veletza S et al (2012) APOE gene polymorphisms and diabetic peripheral neuropathy. Arch Med Sci 8:583–588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Inanir A, Basol N, Karakus N et al (2013) The importance of association between angiotensin-converting enzyme (ACE) Gene I/D polymorphism and diabetic peripheral neuropathy. Gene 530:253–256

    Article  CAS  PubMed  Google Scholar 

  7. Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28(Suppl 1):8–14

    Article  PubMed  Google Scholar 

  8. Yigit S, Karakus N, Inanir A (2013) Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy. Mol Vis 19:1626–1630

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Papanas N, Vinik AI, Ziegler D (2011) Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 7:682–690

    Article  CAS  PubMed  Google Scholar 

  10. Miranda-Massari JR, Gonzalez MJ, Jimenez FJ et al (2011) Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol 6:260–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jurado J, Ybarra J, Romeo JH et al (2012) Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study. J Diabetes Complicat 26:77–82

    Article  CAS  PubMed  Google Scholar 

  12. Purnamasari D, Widjojo BD, Antono D et al (2012) ACE gene polymorphism and atherosclerotic lesion of carotid artery among offsprings of type 2 diabetes mellitus. Acta Med Indones 44:128–134

    PubMed  Google Scholar 

  13. Mansoor Q, Javaid A, Bilal N et al (2012) Angiotensin-converting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus. J Diabetes 4:257–261

    Article  CAS  PubMed  Google Scholar 

  14. Doria A, Warram JH, Krolewski AS (1994) Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690–695

    Article  CAS  PubMed  Google Scholar 

  15. Osawa N, Koya D, Araki S et al (2007) Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 52:143–151

    Article  CAS  PubMed  Google Scholar 

  16. Zhou D, Ruiter R, Zhang J et al (2012) Angiotensin-converting enzyme I/D polymorphism is not associated with type 2 diabetes in a Chinese population. J Renin Angiotensin Aldosterone Syst 13:372–378

    Article  PubMed  Google Scholar 

  17. Qin X, Li J, Cui Y et al (2012) Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics 22:421–428

    Article  CAS  PubMed  Google Scholar 

  18. Ukinc K, Ersoz HO, Karahan C et al (2009) Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 36:255–261

    Article  CAS  PubMed  Google Scholar 

  19. Goyette P, Sumner JS, Milos R et al (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 7:551

    Article  CAS  PubMed  Google Scholar 

  20. Li JB, Cheng YZ, Shi M et al (2011) The relationship between plasma homocysteine levels and diabetic peripheral neuropathy. Chin J Internal Med 50:14–17

    CAS  Google Scholar 

  21. Jianbo L, Yuche C, Ming S et al (2011) Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Res Clin Pract 93:38–42

    Article  PubMed  Google Scholar 

  22. Ambrosch A, Dierkes J, Lobmann R et al (2001) Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 18:185–192

    Article  CAS  PubMed  Google Scholar 

  23. da Costa BR, Cevallos M, Altman DG et al (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1:e000048

    Article  PubMed  PubMed Central  Google Scholar 

  24. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805–3820

    Article  PubMed  PubMed Central  Google Scholar 

  25. Peters JL, Sutton AJ, Jones DR et al (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680

    Article  CAS  PubMed  Google Scholar 

  26. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672–3673

    Article  CAS  PubMed  Google Scholar 

  27. Sun L, Chen L, Ren JM et al (2004) Relationship of plasma homocysteine and gene polymorphism of homocysteine metabolism related enzyme with diabetic peripheral neuropathy. Chin J Endocrinol Metab 20:536–537

    CAS  Google Scholar 

  28. Hibberd ML, Millward BA, Demaine AG (1997) The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complicat 11:2–8

    Article  CAS  PubMed  Google Scholar 

  29. Ito H, Tsukui S, Kanda T et al (2002) Angiotensin-converting enzyme insertion/deletion polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria. J Int Med Res 30:476–482

    Article  CAS  PubMed  Google Scholar 

  30. Toffoli G, Russo A, Innocenti F et al (2003) Effect of methylenetetrahydrofolate reductase 677C--> T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294–299

    Article  CAS  PubMed  Google Scholar 

  31. Xuan C, Bai XY, Gao G et al (2011) Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res 42:677–685

    Article  CAS  PubMed  Google Scholar 

  32. Ilhan N, Kucuksu M, Kaman D et al (2008) The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39:125–130

    Article  CAS  PubMed  Google Scholar 

  33. Dhar S, Ray S, Dutta A et al (2012) Polymorphism of ACE gene as the genetic predisposition of coronary artery disease in Eastern India. Indian Heart J 64:576–581

    Article  PubMed  PubMed Central  Google Scholar 

  34. Mollnau H, Wendt M, Szocs K et al (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58–E65

    Article  PubMed  Google Scholar 

  35. Cotter MA, Cameron NE (2003) Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73:1813–1824

    Article  CAS  PubMed  Google Scholar 

  36. Pasha MA, Khan AP, Kumar R et al (2002) Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 27:67–70

    Article  PubMed  Google Scholar 

  37. Ay C, Bencur P, Vormittag R et al (2007) The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb Haemost 98:777–782

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Natural Science Foundation of China (81230027, 81401127, 81471219), Shanghai Natural Science Foundation (13ZR1460500, 13ZR1409700), Shanghai Excellent Academic Leaders Project (14XD1403400), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500-14-K06), Shanghai Changhai Hospital Foundation (CH125530900), and Postdoctoral Grant of Secondary Military Medical University. We would like to acknowledge the reviewers for their helpful comments on this paper.

Author information

Authors and Affiliations

  1. Department of Neurology, Shanghai Changhai Hospital, Secondary Military Medical University, No. 168 Changhai Road, Shanghai, 200433, China

    Shuai Wu, Yan Han & Yangtai Guan

  2. Department of Psychology, Qiqihar Mental Health Center, Qiqihar, 161000, China

    Qiang Hu

  3. Department of Pathology, Qiqihar Medical University, Qiqihar, 161000, China

    Xiaojie Zhang

  4. Mental Health Institute, Qiqihar Medical University, Qiqihar, 161000, China

    Guangcheng Cui

  5. Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Zezhi Li

Authors
  1. Shuai Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaojie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guangcheng Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zezhi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yangtai Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zezhi Li or Yangtai Guan.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, S., Han, Y., Hu, Q. et al. Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis. Mol Neurobiol 54, 2435–2444 (2017). https://doi.org/10.1007/s12035-016-9823-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-016-9823-4

Keywords

search

Navigation